Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 4
2011 3
2012 2
2014 8
2015 4
2016 4
2017 5
2018 5
2019 2
2020 2
2021 4
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Results by year
Filters applied: . Clear all
Page 1
Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells.
Sugata K, Matsunaga Y, Yamashita Y, Nakatsugawa M, Guo T, Halabelian L, Ohashi Y, Saso K, Rahman MA, Anczurowski M, Wang CH, Murata K, Saijo H, Kagoya Y, Ly D, Burt BD, Butler MO, Mak TW, Hirano N. Sugata K, et al. Among authors: kagoya y. Nat Biotechnol. 2021 Aug;39(8):958-967. doi: 10.1038/s41587-021-00836-4. Epub 2021 Mar 1. Nat Biotechnol. 2021. PMID: 33649568
CAMK2G is identified as a novel therapeutic target for myelofibrosis.
Miyauchi M, Sasaki K, Kagoya Y, Taoka K, Masamoto Y, Yamazaki S, Arai S, Mizuno H, Kurokawa M. Miyauchi M, et al. Among authors: kagoya y. Blood Adv. 2022 Mar 8;6(5):1585-1597. doi: 10.1182/bloodadvances.2020003303. Blood Adv. 2022. PMID: 34521112 Free PMC article.
40 results